Comparison of Remifentanil use in spinal surgery with and without ANI monitoring guidance
Phase 3
- Conditions
- Remifentanil use in surgery with Analgesia Nociception Index.
- Registration Number
- IRCT20180303038923N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients between 18 and 70 years
Patients candidate for spine surgery
ASA Grade I-II
Consent to enter the study
Exclusion Criteria
Patients taking beta-blocker drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dosage of remifentanil during surgery. Timepoint: During surgery. Method of measurement: The amount of remifentanil consumed.
- Secondary Outcome Measures
Name Time Method The rate of pain in recovery in patients. Timepoint: 10, 20, 30 and 60 minutes during recovery. Method of measurement: Visual Analogue Scale.;Further drop in arterial blood saturation below 90% for 60 seconds. Timepoint: 10, 20, 30 and 60 minutes during recovery. Method of measurement: Pulse oximetry.;Complications of fentanyl remedies. Timepoint: During recovery. Method of measurement: According to the recovery nurse.;Global Satisfaction of patients at the end of recovery. Timepoint: At the end of recovery. Method of measurement: Based on 5 point criteria (poor, average, good, very good and excellent).